Immune Caps KeyOxigen, 90 Capsules.

Intestinal release capsules for hormonal balance, energy recovery and muscle support.

  • Olive oil
  • Vitamin K
  • Vitamin D
  • Vitamin B6
KeyOxigen Immune Caps It is a vegan food supplement with a formulation designed by doctors specializing in nutrition, developed for release in the intestine.

The Vitamin B6 helps regulate hormonal activity and normal energy metabolism. Vitamin D contributes to the normal functioning of muscles. Vitamins D and B6 contribute to the normal functioning of the immune system.

COMPOSITION FOR 3 CAPSULES

  • Peroxibiokey 450mg
    • Olive oil 112.5mg
  • VITAMIN K 75μg / 100% VRN
  • VITAMIN D 5μg / 100% VRN
  • VITAMIN B6 9mg / 642.9% VRN

COMPOSITION:

PeroxiBiokey® (Tapioca starch, Olive oil, Dextrose monohydrate, Anti-caking agent (Silicon dioxide), Natural flavours), Bulking agents (Microcrystalline cellulose, Calcium hydrogen phosphate), Anti-caking agent (Silicon dioxide), Menaquinone-7 (Vitamin K), Anti-caking agent (Magnesium salts of fatty acids), Pyridoxine hydrochloride (Vitamin B6), Cholecalciferol (Vitamin D).

Capsule (glazing agent Hydroxypropylmethylcellulose).

  • PEROXIBIOKEY®Unique manufacturing process by controlled diffusion of filtered ozone gas over Olive and Sunflower Oils, is obtained at low temperatures and in stable and controlled conditions, avoiding the degradation of the ingredient and respecting its properties.

 

IMPORTANT: Although in principle there are no contraindications, it is not recommended in case of hypersensitivity or allergy to any of the components of the formulation.

 

44,80 

1 in stock

Join our newsletter

This website uses its own and third-party cookies for its correct functioning and for analytical purposes. It contains links to third-party websites with third-party privacy policies that you may or may not accept when you access them. By clicking the Accept button, you agree to the use of these technologies and the processing of your data for these purposes. More information
Privacy

Page under update. We apologize for the inconvenience.